Big Pharma Split (TSX:PRM) Price-to-Operating-Cash-Flow : 1.73 (As of Jun. 01, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Price-to-Operating-Cash-Flow?

As of today (2024-06-01), Big Pharma Split's share price is C$14.05. Big Pharma Split's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$8.13. Hence, Big Pharma Split's Price-to-Operating-Cash-Flow Ratio for today is 1.73.

The historical rank and industry rank for Big Pharma Split's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSX:PRM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.25 Med: 3.34 Max: 20.98
Current: 1.78

During the past 7 years, Big Pharma Split's highest Price-to-Operating-Cash-Flow Ratio was 20.98. The lowest was 1.25. And the median was 3.34.

TSX:PRM's Price-to-Operating-Cash-Flow is ranked better than
95.44% of 1031 companies
in the Asset Management industry
Industry Median: 12.49 vs TSX:PRM: 1.78

Big Pharma Split's Cash Flow from Operations per share for the six months ended in Dec. 2023 was C$1.11. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$8.13.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Big Pharma Split was 1202.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 30.70% per year.

During the past 7 years, Big Pharma Split's highest 3-Year average Operating Cash Flow per Share Growth Rate was 30.70% per year. The lowest was -53.10% per year. And the median was -11.20% per year.

Big Pharma Split Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Big Pharma Split's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Price-to-Operating-Cash-Flow Chart

Big Pharma Split Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

1.94

3.07

19.49

1.41

Big Pharma Split Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial								-	-	19.49	-	1.41

Competitive Comparison of Big Pharma Split's Price-to-Operating-Cash-Flow

For the Asset Management subindustry, Big Pharma Split's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Big Pharma Split's Price-to-Operating-Cash-Flow Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's Price-to-Operating-Cash-Flow falls into.

Big Pharma Split Price-to-Operating-Cash-Flow Calculation

Big Pharma Split's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	14.05	/	8.126
	=	1.73

Big Pharma Split's Share Price of today is C$14.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Big Pharma Split's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$8.13.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Big Pharma Split Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split (TSX:PRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

PRM.PR.A.PFD:Canada

Address

610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5

Website

https://www.harvestportfolios.com

Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Executives

Michael Kovacs

Director, Senior Officer